Skip to search formSkip to main contentSkip to account menu

MPTP Poisoning

Known as: MPTP Neurotoxicity Syndrome, MPTP-Induced Parkinsonism, Neurotoxicity Syndromes, MPTP 
A condition caused by the neurotoxin MPTP which causes selective destruction of nigrostriatal dopaminergic neurons. Clinical features include… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
  • 2017
  • Corpus ID: 53456257
of the lecture on the 2nd International Conference "Hypoxia in Medicine" A number of studies have demonstrated that short term… 
2009
2009
The role of nitric oxide (NO) in modulation of sensitivity ofmitochondnal permeability transition pore (MPTP) opening under… 
2000
2000
Loss of striatal dopamine has been associated with an increase in striatal enkephalin expression. However, the relationship… 
1994
1994
Deprenyl and the Issue of Neuroprotection F. Vingerhoets, MD, Neurodegenerative Disorders Centre, University Hospital, UBC Site… 
1993
1993
It has been suggested that the therapeutic response to electroconvulsive therapy in depressed patients could be mediated by… 
1986
1986
1-Methyl-4-(3-methoxyphenyl)-1,2,3,6-tetrahydropyridine (2) produced persistent depletion of striatal dopamine in mice after four… 
1986
1986
: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) caused marked depletion of dopamine and of its two metabolites, DOPAC (3,4… 
1984
1984
MPTP(N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) induces parkinsonism in animals and man by selectively destroying dopaminergic…